Nabumetone causes side effects that are broadly similar to other nonsteroidal anti-inflammatory drugs (NSAIDs), with digestive complaints like stomach pain, diarrhea, and indigestion being the most common. What sets nabumetone apart is how it gets processed in the body: it is a prodrug, meaning the pill you swallow is not the active substance. It converts to its active form only after passing through the liver, and that conversion step spares the stomach lining from much of the direct irritation that other NSAIDs cause. The side-effect profile is real but, by most measures, milder than what you would expect from drugs in the same class.
The Most Frequently Reported Side Effects
In long-term safety studies, the side effects that showed up most often fell into two categories: whole-body complaints and digestive-system complaints. Abdominal pain, diarrhea, and dyspepsia (a catch-all for nausea, bloating, and general stomach discomfort) each occurred in more than 10% of patients tracked over extended treatment periods. Gastrointestinal ulcers were confirmed in about 0.7% of patients, and only about 0.4% showed meaningful elevations in liver enzymes. Two patients in the long-term pool had notable rises in kidney function markers like serum creatinine.1PubMed. An overview of the long-term safety experience of nabumetone
In a large UK surveillance study that tracked over 10,800 arthritis patients prescribed nabumetone by their regular doctors, about 12% stopped the drug because of side effects, and only 0.1% experienced a serious event that could plausibly be tied to the medication. Seven of those 11 serious events were gastrointestinal bleeding.2PubMed. A 12-month postmarketing surveillance study of nabumetone. A preliminary report In a head-to-head clinical trial comparing nabumetone with another treatment for knee osteoarthritis, about a quarter of patients on nabumetone had drug-related side effects, and roughly 10% dropped out because of them.3PubMed. Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis
So to put it plainly: the average person taking nabumetone will most likely notice some stomach-related discomfort if they notice anything at all. Serious complications are uncommon, but they are not zero.
Why Nabumetone Is Easier on the Stomach Than Most NSAIDs
This is the single most studied aspect of nabumetone’s safety, and the evidence is unusually consistent. Nabumetone itself is non-acidic. After you swallow it, it undergoes extensive first-pass metabolism in the liver, converting into its active metabolite, called 6-MNA. That metabolite preferentially inhibits the COX-2 enzyme, the one linked to inflammation, rather than the COX-1 enzyme that helps maintain the protective mucus lining of the stomach.4PubMed. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis Because the pill itself never directly irritates the stomach wall the way an acidic NSAID would, the rate of serious gastrointestinal damage drops substantially.
A meta-analysis looking at both clinical trial and postmarketing data found that perforations, ulcers, and bleeds (often grouped together as “PUBs”) were 10 to 36 times more likely in patients taking a comparator NSAID than in those on nabumetone. In postmarketing surveillance covering over 17,500 patient-years of treatment, only one such event occurred per 500 patient-years. Hospitalizations for gastrointestinal problems were nearly four times higher in patients on other NSAIDs.5The American Journal of Medicine. Gastrointestinal safety profile of nabumetone: a meta-analysis
Pooled data from eight randomized controlled trials showed the cumulative frequency of perforations, ulcers, and bleeds was 0.03% for nabumetone compared with 1.4% for comparator NSAIDs.6PubMed. Safety of the nonselective NSAID nabumetone: focus on gastrointestinal tolerability When nabumetone was tested head-to-head against diclofenac, naproxen, ibuprofen, and piroxicam, ulcers occurred in 0.03% of nabumetone patients versus 0.5% of those on other NSAIDs. Meaningful drops in hemoglobin, a sign of hidden bleeding, were also less common with nabumetone than with diclofenac, ibuprofen, or piroxicam.7The American Journal of Medicine. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis
None of this means nabumetone is harmless to the stomach. Abdominal pain and indigestion still happen. But the risk of something dangerous, a bleeding ulcer or a perforation, is a fraction of what you face with traditional NSAIDs. If you have a history of stomach ulcers or gastrointestinal bleeding, that distinction matters quite a bit.
Diarrhea as a Nabumetone-Specific Quirk
One side effect that actually appears more often with nabumetone than with some other NSAIDs is diarrhea. In trials comparing it with ibuprofen in elderly patients, diarrhea was reported by about 6.6% of those on nabumetone versus 0.9% on ibuprofen.8The American Journal of Medicine. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly Raising the dose to 2,000 mg per day also seemed to increase diarrhea in a dose-related way.9PubMed. An overview of the long-term safety experience of nabumetone This is worth knowing because if you start nabumetone and develop loose stools, it is a recognized effect of the drug and not necessarily a sign of something more worrisome. It also tends to be manageable and often resolves if the dose is adjusted.
Blood Pressure and Cardiovascular Concerns
All NSAIDs carry warnings about cardiovascular risk, and nabumetone is no exception. The concern is that these drugs can raise blood pressure, retain fluid, and in some cases increase the risk of heart attack or stroke with prolonged use. But the degree of blood pressure disruption varies substantially from one NSAID to another.
A randomized trial in patients already taking ACE inhibitors for high blood pressure compared the effects of nabumetone, celecoxib, ibuprofen, and a placebo. Ibuprofen caused significant increases in both systolic and diastolic blood pressure compared with placebo. Nabumetone did not. About 16.7% of ibuprofen patients had systolic blood pressure increases of clinical concern, compared with 5.5% of nabumetone patients and just 1.1% on placebo.10American Journal of Hypertension. Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors That 5.5% figure is not zero, but it is dramatically lower than ibuprofen’s impact. If you already have high blood pressure and need an NSAID, this is worth discussing with your doctor.
Kidney Effects
NSAIDs as a class can reduce blood flow to the kidneys, lower the filtration rate, and cause the body to retain sodium and fluid. In vulnerable patients, particularly those who are dehydrated, have heart failure, or have existing kidney disease, these effects can snowball into acute kidney failure, swelling, or worsening blood pressure. NSAIDs can also, in rare cases, cause a type of kidney inflammation called interstitial nephritis.
In clinical trials, nabumetone affected kidney function in less than 1% of patients regardless of sex or age.11PubMed. Therapeutic implications associated with renal studies of nabumetone An animal study found that while nabumetone did reduce kidney function in isolated kidneys tested outside the body, it did not affect kidney function in live rats during either short-term or long-term use, suggesting the body has compensatory mechanisms that protect the kidneys during normal use.12Experimental Nephrology. Renal Effects of Nabumetone, a COX-2 Antagonist: Impairment of Function in Isolated Perfused Rat Kidneys Contrasts with Preserved Renal Function in vivo
The practical upshot: if your kidneys are healthy and you are well hydrated, nabumetone is unlikely to cause kidney problems. But if you have moderate-to-severe kidney disease, are on diuretics, or have conditions that reduce your circulating blood volume, the risk goes up. Your doctor may want to check your kidney function periodically while you are on the drug, especially if treatment lasts more than a few weeks.
Liver Enzyme Elevations
Liver toxicity is a known risk with several NSAIDs, and diclofenac in particular has a reputation for pushing liver enzymes up. Nabumetone performs well by comparison. In long-term studies, only about 0.4% of nabumetone-treated patients had marked elevations in both ALT and AST, the two enzymes that signal liver stress.13PubMed. An overview of the long-term safety experience of nabumetone
A trial in elderly patients found that 4% of those taking diclofenac had ALT values more than twice the upper limit of normal, while none of the nabumetone patients did.14Journal of Clinical Gastroenterology. Treatment of Elderly Patients with Nabumetone or Diclofenac In a broader comparison with diclofenac, naproxen, ibuprofen, and piroxicam, significantly more diclofenac-treated patients withdrew from the trial because of elevated liver enzymes, while this was not a meaningful issue in the nabumetone group.15The American Journal of Medicine. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis Patients with pre-existing liver impairment may need dose adjustments, since the liver is responsible for converting nabumetone into its active form.16PubMed. Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?
Platelet Function and Bleeding Risk
One of the more underappreciated advantages of nabumetone is that it is gentler on platelets than many other NSAIDs. Aspirin and traditional NSAIDs inhibit platelets strongly, which is why people bruise more easily or bleed more freely while taking them. Nabumetone does inhibit platelet function to some degree, but the effect is significantly less pronounced than with low-dose aspirin.17PubMed. Effects of nabumetone on platelet function in healthy volunteers
This matters especially if you take a blood thinner like warfarin. Studies in patients and healthy volunteers stabilized on warfarin found that nabumetone did not alter prothrombin time or the international normalized ratio (INR), the two measures used to gauge how well warfarin is working. Combined with its lower rate of gastrointestinal damage and its milder platelet effects, researchers have suggested that nabumetone may be a preferred option when someone on warfarin also needs an anti-inflammatory.18The American Journal of Medicine. Nonsteroidal antiinflammatory drug use in patients receiving warfarin: Emphasis on nabumetone
How Older Adults Respond
Elderly patients metabolize nabumetone more slowly, leading to higher blood levels of the active metabolite compared with younger adults. That might sound like a recipe for more side effects, but the clinical picture is more nuanced. In head-to-head trials, nabumetone was as effective as diclofenac, naproxen, ibuprofen, and piroxicam in older patients with osteoarthritis or rheumatoid arthritis, and caused significantly less abdominal pain than ibuprofen or diclofenac. Only about 1% of elderly nabumetone patients withdrew due to side effects, compared with nearly 5% on piroxicam.19The American Journal of Medicine. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly
An interesting finding from these elderly-focused trials: when the nabumetone dose was doubled from 1,000 mg to 2,000 mg per day, there was no proportional increase in side effects. With other NSAIDs, higher doses reliably meant more problems. This suggests nabumetone has a wider therapeutic window in older adults. That said, pharmacokinetic data still show that elderly patients and those with active rheumatic disease or liver impairment may need dose adjustments because of slower elimination of the drug.20PubMed. Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?
Allergic and Hypersensitivity Reactions
Some people who react badly to one NSAID assume they cannot take any of them. This is often true, particularly for people who experience respiratory reactions like asthma flares or nasal polyp swelling after taking aspirin or ibuprofen. But nabumetone’s COX-2 preference gives it an edge here as well. In a study of patients with documented NSAID intolerance, about 94% tolerated nabumetone at a 1-gram dose. Even at the higher 2-gram dose, tolerability was still about 84%.21PubMed. Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance
This does not mean you should self-prescribe nabumetone if you have a history of NSAID reactions. These tolerance tests were conducted under medical supervision for good reason. But it does mean that if your doctor is looking for an anti-inflammatory option for someone who has reacted to other NSAIDs in the past, nabumetone is one of the drugs they are likely to consider.
Taking Nabumetone With Food
Unlike many medications where food merely affects how fast the drug kicks in, food meaningfully increases how much nabumetone your body absorbs. When taken with a meal, both the peak blood levels and the total amount of active metabolite in circulation rise significantly compared with taking it on an empty stomach.22PubMed. Nabumetone–a novel anti-inflammatory drug: the influence of food, milk, antacids, and analgesics on bioavailability of single oral doses This is why nabumetone is typically recommended to be taken with food or milk. The tolerance was excellent in both fasting and fed conditions in the study, so it is not about preventing stomach upset alone; it is about getting more of the drug to actually work.
This has a practical side-effect implication. If you switch from taking nabumetone with a full meal to taking it on an empty stomach (or vice versa), you are effectively changing your dose. Someone who experiences side effects after changing their eating habits around their pill may be inadvertently getting more or less of the drug than before.
How Nabumetone Compares in Real-World Costs and Safety
An insurance claims analysis compared nabumetone with two other NSAIDs often marketed as having favorable gastrointestinal profiles, etodolac and oxaprozin. Looking at actual hospital admissions and outpatient claims for upper GI ulcers or bleeding, the three drugs performed similarly. About 4% to 5% of patients in each group had at least one outpatient claim related to upper GI ulcers or bleeding, and total healthcare costs over nine months were roughly the same at about $3,000 per patient.23ScienceDirect. Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis The takeaway is that nabumetone’s GI advantage shows up most clearly when compared with traditional NSAIDs like ibuprofen, naproxen, and diclofenac. When compared with other NSAIDs specifically designed to be easier on the stomach, the differences narrow.
Pregnancy and Nabumetone
All NSAIDs, nabumetone included, are generally avoided in the third trimester of pregnancy because of the risk of premature closure of the ductus arteriosus, a critical blood vessel in the fetal heart. Earlier in pregnancy, NSAID use is an area of ongoing debate, with concerns about potential effects on fetal kidney development and amniotic fluid levels. If you are pregnant or planning to become pregnant, the standard advice is to avoid nabumetone and discuss alternatives with your healthcare provider. This is a class-wide concern, not something unique to nabumetone.
Central Nervous System and Skin Reactions
Less commonly, nabumetone can cause headaches, dizziness, drowsiness, or ringing in the ears. Skin reactions including rash, itching, and occasionally more serious hypersensitivity responses like photosensitivity have been reported. These effects are relatively uncommon and tend to be mild when they occur, but they are worth knowing about so you do not attribute them to something else if they develop shortly after starting the medication. As with any drug, a new and unexplained rash warrants a conversation with your prescriber, particularly because rare but severe skin reactions like Stevens-Johnson syndrome are a theoretical risk with virtually all NSAIDs.